During the past decade, China-Japan Union Hospital of Jilin University conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 7 clinical trials were completed, i.e. on average, 21.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "China-Japan Union Hospital of Jilin University" #1 sponsor was "Shanghai Jiao Tong University School of Medicine" with 3 trials, followed by "Takeda" with 3 trials sponsored, "BeyondSpring Pharmaceuticals Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "China-Japan Union Hospital of Jilin University" #1 collaborator was "China-Japan Union Hospital, Jilin University" with 5 trials as a collaborator, "The First Hospital of Jilin University" with 3 trials as a collaborator, "Fujian Medical University Union Hospital" with 2 trials as a collaborator, "Hebei General Hospital" with 2 trials as a collaborator and "Jiangxi Provincial Cancer Hospital" with 2 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 129 trials.

According to Clinical.Site data, the most researched conditions in "China-Japan Union Hospital of Jilin University" are "Chemotherapy-induced Neutropenia" (2 trials), "Coronary Heart Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "China-Japan Union Hospital of Jilin University" in a lesser frequency.

Most popular intervention types in "China-Japan Union Hospital of Jilin University" are "Drug" (30 trials), "Other" (6 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "placebo" (3 trials), "Bismuth-Containing Quadruple Therapy" (2 trials), "Docetaxel, doxorubicin, and cyclophosphamide (TAC)" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "China-Japan Union Hospital of Jilin University" are 39 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "China-Japan Union Hospital of Jilin University". 1 are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in China-Japan Union Hospital of Jilin University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in China-Japan Union Hospital of Jilin University, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".